cgp 42112a has been researched along with lysophosphatidylcholines in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
---|---|---|---|---|---|
233 | 0 | 35 | 5,058 | 39 | 976 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, C; Gaa, ST; Lokuta, AJ; Rogers, TB; Wang, HE | 1 |
1 other study(ies) available for cgp 42112a and lysophosphatidylcholines
Article | Year |
---|---|
Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Cells, Cultured; Cinnamates; Eicosanoids; Heart; Heart Ventricles; Imidazoles; Inositol Phosphates; Kinetics; Lysophosphatidylcholines; Myocardium; Oligopeptides; ortho-Aminobenzoates; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Second Messenger Systems; Tetrazoles | 1994 |